Bank of America (NYSE: BAC), Abbott Laboratories (NYSE: ABT), Pharmasset (NASDAQ: VRUS), Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Safety First Trust (NYSE: ATA) and Baxter International Inc. (NYSE: BAX) had ratings on them reiterated by analysts.
JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Overweight" rating on Bank of America (BAC). They have a price target of $13.00 on the company.
JPMorgan Chase & Co. reiterated its "Neutral" rating on Abbott Laboratories (ABT). They have a price target of $55.00 on the company.
Morgan Stanley (NYSE:MS) reiterated its "Overweight" rating on Pharmasset (VRUS).
Piper Jaffray (NYSE:PJC) reiterated its "Overweight" rating on Achillion Pharmaceuticals Inc. (ACHN). They have a price target of $12.00 on the company.
Piper Jaffray reiterated its "Overweight" rating on Safety First Trust (ATA).
Morgan Keegan reiterated its "Overweight" rating on Baxter International Inc. (BAX). They have a price target of $67.00 on the company.
No comments:
Post a Comment